keyword
MENU ▼
Read by QxMD icon Read
search

Prognosis cirrhosis

keyword
https://www.readbyqxmd.com/read/30113926/analysis-of-survival-and-prognostic-factors-in-treatment-of-hepatocellular-carcinoma-in-spanish-patients-with-drug-eluting-bead-transarterial-chemoembolization
#1
Jordi Sánchez-Delgado, Mercedes Vergara, Salvador Machlab, Alba Lira, Carlos Gómez Zaragoza, Eva Criado, Mercè Rosinach, Lissette Batista, Beatriz Arau, Mercè Roget, Jordi Ortiz, Caridad Garcia, Pau Sort, Meritxell Casas, Blai Dalmau, Montserrat Forné, Joan Falcó, Mireia Miquel
BACKGROUND AND AIM: Drug-eluting bead transarterial chemoembolization (DEB-TACE) improves the survival of patients with hepatocellular carcinoma (HCC), intermediate stage [i.e. Barcelona Clinic Liver Cancer-B (BCLC-B)]. The aim of our study was to analyse the overall survival (OS) and prognostic factors of patients with HCC treated with DEB-TACE. PATIENTS AND METHODS: Patients' clinical course was recorded from January 2005 to July 2014. The median OS was obtained by the Kaplan-Meier method and compared using the log-rank test...
August 15, 2018: European Journal of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/30097237/clinical-and-circulating-biomarkers-of-survival-and-recurrence-after-radiofrequency-ablation-in-patients-with-hepatocellular-carcinoma
#2
REVIEW
Matteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, Emanuela Scarpi, Serena De Matteis, Gabriele Donati, Giorgio Ercolani, Mario Scartozzi, Luca Faloppi, Alessandro Passardi, Emiliano Tamburini, Martina Valgiusti, Giorgia Marisi, Giovanni Luca Frassineti, Andrea Casadei Gardini
Radiofrequency ablation (RFA) is an effective local treatment for curative intent in patients with cirrhosis of the liver and hepatocellular carcinoma (HCC) with diameter <3 cm. Several meta-analyses have shown that RFA and surgical resection are comparable in terms of their impact on overall survival. The only clinical data available on markers that are predictive of recurrence and survival after RFA treatment are based on retrospective observational studies. Prospective randomized trials are thus needed to further research in this area...
September 2018: Critical Reviews in Oncology/hematology
https://www.readbyqxmd.com/read/30094402/l-carnitine-suppresses-loss-of-skeletal-muscle-mass-in-patients-with-liver-cirrhosis
#3
Masatsugu Ohara, Koji Ogawa, Goki Suda, Megumi Kimura, Osamu Maehara, Tomoe Shimazaki, Kazuharu Suzuki, Akihisa Nakamura, Machiko Umemura, Takaaki Izumi, Naoki Kawagishi, Masato Nakai, Takuya Sho, Mitsuteru Natsuizaka, Kenichi Morikawa, Shunsuke Ohnishi, Naoya Sakamoto
Liver cirrhosis (LC) is a major cause of secondary sarcopenia. Sarcopenia makes the prognosis worse; thus, novel therapeutic options for sarcopenia in patients with LC are urgently required as they are currently limited. In this retrospective study, 158 patients with LC were screened, and 35 of those patients who were treated with L-carnitine for more than 6 months and for whom skeletal muscle mass changes could be evaluated by computer tomography were enrolled. Of the 158 patients, 79 patients who did not receive L-carnitine supplementation served as controls...
August 2018: Hepatology communications
https://www.readbyqxmd.com/read/30087805/emerging-therapies-in-advanced-hepatocellular-carcinoma
#4
REVIEW
Sowmini Medavaram, Yue Zhang
Background: Prognosis is very poor for advanced HCC patients partially due to lack of effective systemic treatment. Sorafenib was the only approved agent for advanced HCC since 2007 until recent breakthroughs. In this article, we will review the newer approved and promising agents in the treatment of advanced HCC in the first line setting and beyond progression. Main body: The Food and Drug Administration approved sorafenib as it demonstrated 3 months overall survival benefit compared to placebo in the first line setting over 10 years ago...
2018: Experimental Hematology & Oncology
https://www.readbyqxmd.com/read/30087705/pentraxin-3-overexpression-accelerated-tumor-metastasis-and-indicated-poor-prognosis-in-hepatocellular-carcinoma-via-driving-epithelial-mesenchymal-transition
#5
Tao Song, Cong Wang, Cheng Guo, Qingguang Liu, Xin Zheng
As a pattern recognition receptor, pentraxin 3 (PTX3) has been found to exert the pleiotropic roles on a variety of cancers. However, the accurate clinical significance of PTX3 in hepatocellular carcinoma (HCC) has not been well defined. The aim of the present investigation was to determine the expression characteristics, prognostic significance, and the relevant biological effect of PTX3 in HCC. The expression of PTX3 was evaluated in tumor and adjacent liver tissues from 210 HCC patients using immunohistochemistry staining...
2018: Journal of Cancer
https://www.readbyqxmd.com/read/30087519/transjugular-intrahepatic-portosystemic-shunt-placement-for-refractory-ascites-review-and-update-of-the-literature
#6
REVIEW
Ana Cecilia Burgos, Bartley Thornburg
Ascites is the most common complication of cirrhosis, impairs quality of life, and carries a poor prognosis. Transjugular intrahepatic portosystemic shunt (TIPS) is a well-validated therapy for refractory ascites and is superior at reducing the accumulation of fluid compared with paracentesis. More recent evidence has shown that TIPS also provides an improved transplant-free survival compared with paracentesis. To maximize the clinical efficacy and survival advantage, proper patient selection is crucial. While current guidelines recommend that elective TIPS for ascites should be performed only in patients with MELD ≤ 18, recent literature suggests that elective TIPS safely and effectively controls ascites and potentially provides a survival advantage in patients with higher MELD scores (≤ 24)...
August 2018: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/30087517/clinical-assessment-and-management-of-portal-hypertension
#7
REVIEW
Jacob Kibrit, Ruben Khan, Barbara H Jung, Sean Koppe
The development of portal hypertension in a patient with cirrhosis portends a poor prognosis. Untreated or progressive portal hypertension has serious clinical outcomes, which are often fatal. It is important to recognize portal hypertension early to delay progression and to treat complications of portal hypertension as they arise. This review will focus on the clinical assessment and management of portal hypertension.
August 2018: Seminars in Interventional Radiology
https://www.readbyqxmd.com/read/30085405/nfatc1-is-a-tumor-suppressor-in-hepatocellular-carcinoma-and-induces-tumor-cell-apoptosis-by-activating-the-fasl-mediated-extrinsic-signaling-pathway
#8
Sanrong Xu, Penghao Shu, Song Zou, Xiaofeng Shen, Yuanqian Qu, Yong Zhang, Kang Sun, Jin Zhang
Nuclear factor of activated T cells (NFAT) is a family of transcription factors that have important functions in many tumors. However, the expression level and functional role of NFAT in hepatocellular carcinoma (HCC) remain unclear. In this study, we showed that NFATc1 expression was decreased in both HCC tissues and cell lines. Low expression of NFATc1 was correlated with larger tumor size, advanced tumor-node-metastasis (TNM) stage, high serum AFP level, and liver cirrhosis. Furthermore, patients with low NFATc1 expression exhibited poor prognosis...
August 7, 2018: Cancer Medicine
https://www.readbyqxmd.com/read/30078038/putting-it-all-together-established-and-emerging-mri-techniques-for-detecting-and-measuring-liver-fibrosis
#9
REVIEW
Suraj D Serai, Andrew T Trout, Alexander Miethke, Eric Diaz, Stavra A Xanthakos, Jonathan R Dillman
Chronic injury to the liver leads to inflammation and hepatocyte necrosis, which when untreated can lead to myofibroblast activation and fibrogenesis with deposition of fibrous tissue. Over time, liver fibrosis can accumulate and lead to cirrhosis and end-stage liver disease with associated portal hypertension and liver failure. Detection and accurate measurement of the severity of liver fibrosis are important for assessing disease severity and progression, directing patient management, and establishing prognosis...
August 2018: Pediatric Radiology
https://www.readbyqxmd.com/read/30067250/clinical-implications-of-telomere-dysfunction-in-lung-fibrosis
#10
Maria Molina-Molina, Raphael Borie
PURPOSE OF REVIEW: Telomere attrition has been proposed as one of the aging hallmarks in pulmonary fibrosis. Telomere shortening and telomerase gene mutations have been widely evaluated in recent years. Reduced telomere length may be identified in a quarter of patients with sporadic idiopathic pulmonary fibrosis (IPF) and half of those cases with family aggregation. However, telomere studies have not transferred from the research field to the clinic. This review is focused on our current understanding of the pathogenic implication of telomere dysfunction in lung fibrosis and its relevance in the clinical setting...
September 2018: Current Opinion in Pulmonary Medicine
https://www.readbyqxmd.com/read/30066417/idiopathic-portal-hypertension
#11
Virginia Hernández-Gea, Anna Baiges, Fanny Turon, Juan Carlos Garcia-Pagán
Idiopathic portal hypertension (IPH) is a rare disorder characterized by clinical portal hypertension in the absence of a recognizable cause such as cirrhosis. Laboratory tests often reveal a preserved liver function with anemia, leukopenia, and thrombocytopenia due to splenomegaly. Imaging studies reveal signs of portal hypertension whereas liver stiffness and portal pressure values are usually normal or slightly elevated. Liver biopsy is considered mandatory in order to rule out other causes of portal hypertension, mainly cirrhosis...
July 31, 2018: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://www.readbyqxmd.com/read/30065915/nonalcoholic-fatty-liver-disease-cirrhosis-a-review-of-its-epidemiology-risk-factors-clinical-presentation-diagnosis-management-and-prognosis
#12
REVIEW
Bei Li, Chuan Zhang, Yu-Tao Zhan
Cirrhosis is the common end stage of a number of chronic liver conditions and a significant cause of morbidity and mortality. With the growing epidemic of obesity and metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease worldwide and will become one of the leading causes of cirrhosis. Increased awareness and understanding of NAFLD cirrhosis are essential. To date, there has been no published systematic review on NAFLD cirrhosis. Thus, this article reviews recent studies on the epidemiology, risk factors, clinical presentation, diagnosis, management, and prognosis of NAFLD cirrhosis...
2018: Canadian Journal of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/30063481/transient-elastography-can-stratify-patients-with-child-pugh-a-cirrhosis-according-to-risk-of-early-decompensation
#13
Audrey Dillon, Zita Galvin, Alyshah A Sultan, David Harman, Indra N Guha, Stephen Stewart
BACKGROUND: Compensated cirrhosis has a variable prognosis depending on stage. There are currently no straightforward and robust tools in clinical practice to predict decompensation in Child-Pugh A cirrhosis. We set out to determine whether transient elastography (TE) could be used across liver disease aetiologies to determine risk of decompensation. PATIENTS AND METHODS: Participants were enrolled at two sites (Dublin and Nottingham) and followed up for a minimum of 2 years...
July 30, 2018: European Journal of Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/30060277/-lactic-acidosis-update-2018
#14
Stefan Kluge, Geraldine de Heer, Dominik Jarczak, Axel Nierhaus, Valentin Fuhrmann
Severe hyperlactaemia in intensive care patients is most often due to underlying sepsis or septic, cardiogenic or haemorrhagic shock. Hyperlactaemia is an independent predictor of death in various groups of critically ill patients. With serum lactate values > 10 mmol/l 80 % of the patients die in intensive care, and if the severe lactic acidosis persists for 48 hours, all patients die. Increased lactate levels require immediate diagnostic work-up and classification. The new sepsis definition requires a serum lactate > 2 mmol/l for septic shock with adequate volume substitution and vasopressor administration in order to achieve a mean arterial pressure in persistent hypotension ≥ 65 mmHg...
August 2018: Deutsche Medizinische Wochenschrift
https://www.readbyqxmd.com/read/30057907/fibrosis-4-model-influences-results-of-patients-with-hepatocellular-carcinoma-undergoing-hepatectomy
#15
Haiqing Wang, Aixiang Liu, Wentao Bo, Xielin Feng, Yong Hu, Lang Tian, Hui Zhang, Xiaoli Tang, Lixia Zhang
Background: Several noninvasive models based on routine laboratory index have been developed to predict liver fibrosis. Our aim is to discuss whether these indexes could predict prognosis in patients with hepatocellular carcinoma undergoing hepatectomy. Methods: This study retrospectively enrolled 788 consecutive hepatocellular carcinoma patients undergoing liver resection in the cohort. Univariate and multivariate analysis were used to identify the risk factors of complications, survival, and disease-free survival...
2018: BioMed Research International
https://www.readbyqxmd.com/read/30051372/prognostic-significance-of-preoperative-controlling-nutritional-status-conut-score-in-patients-undergoing-hepatic-resection-for-hepatocellular-carcinoma-a-multi-institutional-study
#16
Norifumi Harimoto, Tomoharu Yoshizumi, Shoichi Inokuchi, Shinji Itoh, Eisuke Adachi, Yasuharu Ikeda, Hideaki Uchiyama, Tohru Utsunomiya, Kiyoshi Kajiyama, Koichi Kimura, Fumiaki Kishihara, Keishi Sugimachi, Eiji Tsujita, Mizuki Ninomiya, Kengo Fukuzawa, Takashi Maeda, Ken Shirabe, Yoshihiko Maehara
BACKGROUND: The Controlling Nutritional Status (CONUT) score is an objective tool that is widely used to assess the nutritional status in patients, including those with cancer. The relationship between the CONUT score and prognosis in patients who have undergone hepatic resection has not been evaluated in a multi-institutional study. METHODS: Data were retrospectively collected for 2461 consecutive patients with hepatocellular carcinoma (HCC) who had undergone hepatic resection with curative intent at 13 institutions between January 2004 and December 2015...
July 26, 2018: Annals of Surgical Oncology
https://www.readbyqxmd.com/read/30050945/role-of-hepatitis-e-virus-infection-in-acute-on-chronic-liver-failure
#17
REVIEW
Mario Frias, Pedro López-López, Antonio Rivero, Antonio Rivero-Juarez
Chronic liver disease (CLD) with a variety of causes is currently reported to be one of the main causes of death worldwide. Patients with CLD experience deteriorating liver function and fibrosis, progressing to cirrhosis, chronic hepatic decompensation (CHD), end-stage liver disease (ESLD), and death. Patients may develop acute-on-chronic liver failure (ACLF), typically related to a precipitating event and associated with increased mortality. The objective of this review was to analyze the role of acute hepatitis E virus (HEV) infection in patients with CLD, focusing on the impact of this infection on patient survival and prognosis in several world regions...
2018: BioMed Research International
https://www.readbyqxmd.com/read/30046595/twist-expression-in-circulating-hepatocellular-carcinoma-cells-predicts-metastasis-and-prognoses
#18
Liang-Chun Yin, Zhen-Chao Luo, Yan-Xin Gao, Yang Li, Qing Peng, Yi Gao
Hepatocellular carcinoma (HCC) is one of the leading malignancies worldwide. Enumeration of circulating tumor cells (CTCs) has been demonstrated to be a prognostic indicator in HCC. Twist plays a critical role in metastasis and has been proposed as a biomarker for epithelial-mesenchymal transition (EMT). However, links between the expression of Twist in CTCs and HCC clinical parameters are still unclear. This study aims to evaluate the relationship between Twist expression in CTCs and clinicohistopathological risk factors of HCC...
2018: BioMed Research International
https://www.readbyqxmd.com/read/30045168/early-readmission-predicts-increased-mortality-in-cirrhosis-patients-after-clostridium-difficile-infection
#19
Andrew J Kruger, Claire Durkin, Khalid Mumtaz, Alice Hinton, Somashekar G Krishna
GOALS: We sought to determine the impact of Clostridium difficile infections (CDI) in cirrhosis by evaluating trends and outcomes of early readmission and mortality. BACKGROUND: The incidence of CDI in cirrhotics is increasing. STUDY: We analyzed the Nationwide Readmissions Database (2011 to 2014) for hospitalized patients with CDI and differentiated them by presence of cirrhosis. Baseline characteristics, surgical rates, and outcomes were collected...
July 24, 2018: Journal of Clinical Gastroenterology
https://www.readbyqxmd.com/read/30042070/the-prognostic-factors-of-hiv-negative-adult-cryptococcal-meningitis-with-a-focus-on-cranial-mri-based-neuroimaging-findings
#20
Wan-Chen Tsai, Chia-Yi Lien, Jun-Jun Lee, Wei-Che Lin, Che-Wei Hsu, Chi-Ren Huang, Nai-Wen Tsai, Chiung-Chih Chang, Cheng-Hsien Lu, Wen-Neng Chang
The prognostic significance of clinical characteristics and neuroimaging features, especially cranial magnetic resonance imaging (MRI)-based neuroimaging features, in patients with human immunodeficiency virus (HIV)-negative cryptococcal meningitis (CM) has rarely been examined in the literature. We analyzed the clinical characteristics and MRI findings of 65 HIV-negative patients (43 men, 22 women, age 19-86 years) collected during a study period of 15 years (January 2001-December 2015). Their underlying conditions included diabetes mellitus, liver cirrhosis, hematologic disorders, autoimmune disorders, malignancy, chronic obstructive pulmonary disease, adrenal insufficiency and organ transplantation, and their clinical presentations included headache, altered consciousness, fever, seizure, visual disturbance and hearing impairment...
July 2, 2018: Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia
keyword
keyword
170509
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"